PROGRAMA CIENTÍFICO
Viernes 23 de Septiembre, 2011

09.00-11.00 Simposio X The contribution of epidemiology to cancer research

Moderadores

  • José María Borràs
    (IDIBELL y Universidad de Barcelona, Barcelona)
  • Gonzalo López-Abente
    (Instituto de Salud Carlos III, Madrid)

Ponentes

  • Gonzalo López-Abente
    (Instituto de Salud Carlos III, Madrid)
    "Impact of cancer in Spain: the eppidemiological approach”
  • Rafael Peris
    Registro Nacional de Tumores Infantiles, Valencia
    “The evaluation of the survival in cancer registries: the National Childhood Cancer Registry of Spain”
  • Carlos Alberto González-Svatetz
    Instituto Catalán de Oncología, Barcelona
    “Nutrition and cancer risk:  where we are, where we go”
  • Nuria Malats
    Centro Nacional de Investigaciones Oncológicas, Madrid
    “Genetic epidemiology in cancer research: opportunities and challenges”

09.00-11.00 Simposio XI Familial cancer

Moderadores

  • Rogelio González-Sarmiento
    (Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain)
  • Javier Benítez
    (Centro Nacional de Investigaciones Oncológicas CNIO / Spanish National Cancer Research Center,  Madrid, Spain)

Ponentes

  • Mercedes Robledo
    Centro Nacional de Investigaciones Oncológicas CNIO / Spanish National Cancer Research Center,  Madrid, Spain
    “Whole-exome sequencing identifies a new gene as a cause of hereditary pheochromocytoma”
  • Conxi Lázaro
    Programa Diagnòstic Molecular Càncer Hereditari (PDMCH)- Institut Català d'Oncologia (ICO), Barcelona, Spain
    Genetic complexity of Neurofibromatosis type 1 (NF1)
  • Antonio Castells
    Hospital Clínico, Barcelona
    “New strategies in the study of Lynch’s syndrome”
  • Jesús Pérez-Losada
    Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain
    “Use of mice models for the location of cancer susceptibility genes”

09.00-11.00 Simposio XII Translational Research in Radiation Oncology

Moderadores

  • Pedro Carlos Lara
    (Radiation Oncology Dept Dr Negrin University Hospital, Las Palmas de Gran Canaria)
  • Ferran Guedea
    (Instituto Catalán de Oncología (ICO), Barcelona)

Ponentes

  • Catharine West
    Manchester Academic Health Science Centre /The University of Manchester, Manchester, UK
    “The Radiogenomics Consortium and understanding the role of genetics in radiotherapy toxicity”
  • Adrian Begg
    The Netherlands Cancer Institute , Amsterdam, Netherlands
    “Prediction of outcome after radiotherapy using expression profiling”
  • Toulany Mahmoud
  • Dept. of Radiation Oncology, Univ. of Tuebingen Tuebingen, Deutchlands
    “Radiation-induced signalling through ErbB receptors and control  of DNA repair””
  • Pedro Carlos Lara
    Radiation Oncology Dept Dr Negrin University Hospital, Las Palmas de Gran Canaria
    “The Major Vault Protein (MVP): from drug resistance to DNA damage repair modulation”

11.00-11.30 Café y visita a pósters 

11.30-13.30 Comunicaciones seleccionadas congreso ASEICA  (3 salas)

SALA A

Moderadores

  • Rosario Perona Abellón
    (Madrid)

SALA B

Moderadores

  • Ángel Rodríguez-Nebreda 
    (Barcelona)
  • José Antonio Rodríguez-Pérez
    (Leioa – Bizkaia)

SALA C

Moderadores

  • Pedro Alfonso Lazo-Zbikowski Taracena
    (Salamanca)
  • Félix Bonilla-Velasco
    (Madrid)

13.30-15.00 Comida y visita a pósters

15.00-17.00 Simposio XIII Novel therapeutic targets in oncology

Moderadores

  • Atanasio Pandiella
    Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain
  • Dolors Colomer
    Hospital Clinic, Barcelona

Ponentes

  • Enrique Ocio
    Hospital Universitario de Salamanca, Salamanca
    “Targetted treatments in oncohaematology”
  • Pilar Lianes
    Hospital Mataró, Barcelona
    “Maintenance in non-small cell lung cancer”
  • Ricardo Sánchez-Prieto
    Facultad de Medicina. Universidad de Castilla-La Mancha , Albacete
    “The biological bases of the antitumoral effect of radiotherapy”
  • Francesc Viñals
    Instituto Catalán de Oncología (ICO) , Barcelona
    “Novel antiangiogenic therapies”

15.00-17.00 Simposio XIV Molecular Diagnostics

Moderadores
 

  • Gabriel Capellá
    (Instituto Catalán de Oncología-ICO. Barcelona)
  • Trinidad Caldes
    (Hospital Clínico San Carlos, Madrid)


Ponentes

  • Xavier Matías Guiu.
    Hospital Arnau de Vilanova.
    “Pathological and molecular classification of endometrial and ovarian cancer:  Perspectives on their clinical application”
  • Iosu Sola
    Universidad de Navarra. Pamplona
    “Quality Control in Molecular Pathology”
  • Fréderic Chibon
    Universidad de Burdeos.
    “Prognostic utility of molecular profiles in sarcomas”
  • Trinidad Caldes
    Laboratorio de Oncología Molecular. Hospital Clínico San Carlos, Madrid
    “The role of genetic markers in Oncology”

17.00 Ceremonia de clausura